Duke Infective Endocarditis Criteria 3.0 for the Clinician: Defining What Is Possible
Clinical Infectious Diseases · 10.04.2024 · 78 (4) · 964-967
DOI: 10.1093/cid/ciae037 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical Infectious Diseases, online erschienen am 08.02.2024. Verfasst von Henry F Chambers und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Endocarditis, Bacterial, Endocarditis, Communicable Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
This commentary summarizes the results and clinical implications of validation studies evaluating the performance of the 2023 Duke-ISCID criteria for infective endocarditis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, California, USA.
- Biostatistics Center, Milken Institute School of Public Health, George Washington University, Washington D.C., USA.
ORCID-Profile: Henry F Chambers, Scott Evans
Zitieren
APA
Chambers, H. F., Zhang, S., & Evans, S. (2024). Duke Infective Endocarditis Criteria 3.0 for the Clinician: Defining What Is Possible. Clinical Infectious Diseases, 78(4), 964-967. https://doi.org/10.1093/cid/ciae037
Vancouver
Chambers HF, Zhang S, Evans S. Duke Infective Endocarditis Criteria 3.0 for the Clinician: Defining What Is Possible. Clinical Infectious Diseases. 2024;78(4):964-967. doi:10.1093/cid/ciae037
BibTeX
@article{Chambers2024,
author = {Chambers, Henry F and Zhang, ShanShan and Evans, Scott},
title = {Duke Infective Endocarditis Criteria 3.0 for the Clinician: Defining What Is Possible},
journal = {Clinical Infectious Diseases},
year = {2024},
volume = {78},
number = {4},
pages = {964--967},
doi = {10.1093/cid/ciae037}
}
EUVIMED